Trials / Completed
CompletedNCT00082251
Safety & Efficacy of a Combination Niacin ER/Simvastatin in Patients With Dyslipidemia: A Dose-Ranging Study - SEACOAST
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- —
- Sponsor
- Kos Pharmaceuticals · Industry
- Sex
- All
- Age
- 21 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to compare the effectiveness and safety of different doses of Niacin ER/Simvastatin (NS), in subjects with elevated fat levels in their blood (dyslipidemia).
Detailed description
The purpose of this study is to compare the efficacy and safety of different doses of Niacin ER/Simvastatin (NS), in subjects with elevated fat levels in their blood (dyslipidemia).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Niacin extended release and simvastatin tablets |
Timeline
- First posted
- 2004-05-05
- Last updated
- 2006-11-01
Source: ClinicalTrials.gov record NCT00082251. Inclusion in this directory is not an endorsement.